Dimopoulos, Meletios A.
Moreau, Philippe
Iida, Shinsuke
Huang, Shang-Yi
Takezako, Naoki
Chng, Wee Joo
Zahlten-Kumeli, Anita
Sersch, Martina A.
Li, Julia
Huang, Mei
Lee, Jae Hoon
Funding for this research was provided by:
Amgen Inc.
Article History
Received: 13 March 2019
Revised: 8 July 2019
Accepted: 9 July 2019
First Online: 6 August 2019
Compliance with ethical standards
:
: MAD reports receiving honoraria and consulting and/or advisory role fees from Celgene, Janssen, Amgen Inc., Novartis, and Takeda, and research funding from Genesis Pharma. PM reports receiving honoraria from and advisory board participation with Amgen Inc., Celgene, Takeda, Janssen, and AbbVie. SI reports receiving research grants and consulting fees from Ono Pharmaceutical Co., Ltd., Janssen, Celgene, Takeda, Bristol-Myers Squibb, and Novartis; and research grants from Chugai, Teijin Pharma, Astellas, Toyama Chemical, Eli Lilly, Kyowa Hakko Kirin, Sanofi, AbbVie, Merck Sharp & Dohme, and Daiichi Sanko. WJC reports receiving research grants from Celgene, Janssen, Novartis, Takeda, and Amgen Inc.; and consulting fees from Celgene, Janssen, Novartis, Takeda, and Amgen Inc. AZ-K, MAS, JL, and MH are employees of and own stock in Amgen Inc. S-YH, NT, and JHL have nothing to disclose.